You searched for Antibody candidate - Page 45 of 69

News and Trends 21 Dec 2020

Late-Stage Success Raises Hopes to Tackle Alzheimer’s via Inflammation

…tests. The test subjects took the candidate in addition to standard Alzheimer’s disease medications. Masitinib is a drug that inhibits tyrosine kinase proteins, which are involved in promoting inflammation. The…

December 21, 2020 - 5 minutesmins - By Victor Kotsev

Best in Biotech 2 Sep 2021

The top 15 biotech companies to find in the Netherlands

…designed to work either alone or in combination with existing therapies. The company’s lead clinical candidate is for advanced stages of head-and-neck cancer and cervical cancer to be used on…

September 2, 2021 - 7 minutesmins - By Clara Rodríguez Fernández

Cell Medica Catapult Therapy TCR Acquisition

News and Trends 21 Jun 2017

British Biotech Tops up its Cancer Pipeline with New TCR Therapy

Cell Medica just acquired Catapult Therapy TCR, set up by UK’s CGT Catapult, gaining the rights to its TCR therapy candidate to treat solid tumors. Cell Medica says it’s all…

June 21, 2017 - 2 minutesmins - By Melanie De Almeida

News and Trends 30 Jun 2021

GSK Raises Eyebrows in Checkpoint Inhibitor Megadeal with iTeos

…iTeos earlier this month centered on an antibody drug that blocks an immune checkpoint called TIGIT. The candidate is currently in phase I testing for advanced solid tumors. The megadeal…

June 30, 2021 - 5 minutesmins - By Victor Kotsev

Expert Advice 23 Feb 2024

Navigating the life sciences job market: Five job boards making your life easier

…strongly believes in specialized job boards and thinks the setback of traditional job boards is that they can easily get overcrowded, making it tough for candidates to get noticed and…

February 23, 2024 - 7 minutesmins - By Jules Adam

Catherine Pickering iOnctura e1575382680993

Interview 22 Jul 2019

Turning Shelved Drugs into a New Promise for Immuno-Oncology

After working for 12 years at Merck, Catherine Pickering decided to take a risk and create iOnctura, a spin-out company exploring a new application in immuno-oncology for a drug candidate…

July 22, 2019 - 5 minutesmins - By Clara Rodríguez Fernández

In Depth 29 Jan 2025

Pancreatic cancer: Oncolytics Biotech, Candel, and CytomX bring promising therapies to the clinic

…cancers showing high expression of EGFR. The candidate in question here is called CX-904. Being a bispecific antibody, it targets both EGFR on cancer cells and the CD3 receptor on…

January 29, 2025 - 8 minutesmins - By Willow Shah-Neville

News and Trends 19 Oct 2022

Domain Therapeutics to start clinical trials of solid tumor treatment

Domain Therapeutics says its immuno-oncology candidate has been cleared in Belgium and France, leading to a phase I clinical trial. It has cleared its clinical trial applications with the ANSM…

October 19, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 28 Feb 2018

Like Finding a Needle in a Haystack: How Are Biotechs Fighting Rare Diseases?

…candidate, MIN-102, for X-linked Adrenoleukodystrophy, spun out Gain Therapeutics last week. This new biotech will use a platform called SEE-Tx to develop pharmacological chaperones for rare metabolic diseases. These small…

February 28, 2018 - 8 minutesmins - By Alex Dale

News and Trends 13 Mar 2018

French Biotech Takes its Oral Diabetes Drug to Phase III

…key secondary endpoints in a Phase IIb study in Japan for its type 2 diabetes candidate Imeglimin. Now, the company plans to go for a Phase III program that could…

March 13, 2018 - 3 minutesmins - By Melanie De Almeida

News and Trends 4 Feb 2020

Swiss Biotech Raises €16M to Treat Autism Spectrum Disorder

…US private equity investors. The Swiss company will use the money to progress its lead candidate treatment for autism spectrum disorder into a phase Ib clinical trial this year. The…

February 4, 2020 - 2 minutesmins - By Jonathan Smith

huntingtons disease gene therapy uniqure2 1

News and Trends 23 Jan 2019

Update: The FDA Green-lights Clinical Trials for Huntington’s Disease Gene Therapy

…the US in late 2019. Published on 23/01/2018: The EMA has given uniQure’s gene therapy candidate for Huntington’s disease Orphan Medicinal Product Designation, which the company hopes to move into…

January 23, 2019 - 3 minutesmins - By Alex Dale

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Antibody candidate

Late-Stage Success Raises Hopes to Tackle Alzheimer’s via Inflammation

The top 15 biotech companies to find in the Netherlands

British Biotech Tops up its Cancer Pipeline with New TCR Therapy

GSK Raises Eyebrows in Checkpoint Inhibitor Megadeal with iTeos

Navigating the life sciences job market: Five job boards making your life easier

Turning Shelved Drugs into a New Promise for Immuno-Oncology

Pancreatic cancer: Oncolytics Biotech, Candel, and CytomX bring promising therapies to the clinic

Domain Therapeutics to start clinical trials of solid tumor treatment

Like Finding a Needle in a Haystack: How Are Biotechs Fighting Rare Diseases?

French Biotech Takes its Oral Diabetes Drug to Phase III

Swiss Biotech Raises €16M to Treat Autism Spectrum Disorder

Update: The FDA Green-lights Clinical Trials for Huntington’s Disease Gene Therapy

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!